17β-Hydroxywortmannin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


17β-Hydroxywortmannin
Description:
17β-Hydroxywortmannin (Wortmannin-17β-ol) is an orally active inhibitor for phosphatidylinositol-3-kinase (PI-3-kinase) with an IC50 of 0.5 nM, suppresses the osteoclast resorption with an IC50 of 10 nM[1]. 17β-Hydroxywortmannin exhibits antitumor activity[2].Product Name Alternative:
Wortmannin-17β-olUNSPSC:
12352005Hazard Statement:
H300+H310+H330Target:
PI3KType:
Reference compoundRelated Pathways:
PI3K/Akt/mTORApplications:
Cancer-Kinase/proteaseField of Research:
Cancer; OthersAssay Protocol:
https://www.medchemexpress.com/17β-hydroxywortmannin.htmlSolubility:
10 mM in DMSOSmiles:
C[C@@]12C3=C(C(C4=C1C(C(O[C@@H]2COC)=O)=CO4)=O)[C@@]5([H])[C@](C[C@H]3OC(C)=O)([C@H](CC5)O)CMolecular Formula:
C23H26O8Molecular Weight:
430.45Precautions:
P260-P262-P264-P270-P271-P280-P284-P302+P352-P304+P340-P330-P361+P364-P403+P233-P405-P501References & Citations:
[1]Hall TJ, et al., Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int. 1995 Apr;56 (4) :336-8.|[2]Zask A, et al., Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy. J Med Chem. 2008 Mar 13;51 (5) :1319-23.Shipping Conditions:
Room temperatureScientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
PI3KCAS Number:
[58053-83-1]
